Pulnovo Medical Announces First Two U.S. Patients Enrolled in PULSE-LHD IDE Clinical Trial of Pulmonary Artery Denervation in Treating Pulmonary Hypertension Associated with Left Heart Disease

Pulnovo Medical announced the enrollment of the first two patients in its PULSE-LHD clinical trial for pulmonary hypertension/heart failure, conducted under U.S. FDA oversight. The update is an early clinical milestone with modest near-term implications for shares, but it supports continued progress toward potential product development.

Analysis

Pulnovo Medical announced the enrollment of the first two patients in its PULSE-LHD clinical trial for pulmonary hypertension/heart failure, conducted under U.S. FDA oversight. The update is an early clinical milestone with modest near-term implications for shares, but it supports continued progress toward potential product development.